Cancer researcher Rene Bernards of the Netherlands
Cancer Institute has been elected as 2018 Fellow of the American
Association for Cancer Research Academy.
Professor Bernards was elected for establishing innovative
strategies to categorize biomarkers of treatment response and
effective treatment combinations, and for pioneering the use of
genetic screening tests to identify and stratify individuals at
risk of developing breast cancer.
On 4 April 2018, the American Association for Cancer Research
(AACR) announced its newly elected class of Fellows of the AACR
Academy, which provides ongoing advice and counsel to the AACR
leadership on scientific topics of timeliness and significance as
well as other matters of importance.
The mission of the
AACR Academy is to recognize and honor distinguished scientists
whose major scientific contributions have propelled significant
innovation and progress against cancer, and to leverage the
expertise of the global brain trust of Fellows of the AACR Academy
to advance the mission of the AACR to prevent and cure all cancers
through research, education, communication, and collaboration.
All Fellows are nominated and elected through an annual
peer-review process conducted by existing Fellows of the AACR
Academy and ratified by the AACR Executive Committee. This process
involves a rigorous assessment of each candidate's scientific
achievements in cancer research and cancer-related sciences.
Consideration of induction and election into the AACR Academy is
restricted to individuals whose work has had a significant and
enduring impact on the cancer research field.
Rene Bernards will be formally inducted into the 2018 class of
Fellows at the AACR Annual Meeting 2018, to be held in
Chicago, April 14-18.